83 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to the offering … , threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any event or development within
8-K
EX-5.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
and sale of the Securities subject to the Registration Statement and is not to be relied upon for any other purpose. In providing this letter, we
8-K
EX-4.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
of this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include … the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
-A filed with the SEC on July 20, 2020 under Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating … in the calendar year and for an aggregate of at least 183 days during a three-year period ending in the current calendar year. Generally, for this purpose, all
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
, 2020 under Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating such description.
We will furnish … a three-year period ending in the current calendar year. Generally, for this purpose, all the days present in the current year, one-third of the days
S-8
ju6ps8qptx4e
15 Feb 24
Registration of securities for employees
4:51pm
S-8
EX-5.1
m945agg y1lzc
15 Feb 24
Registration of securities for employees
4:51pm
S-8
f407g7 k4yuw
15 Feb 24
Registration of securities for employees
4:51pm
8-K
EX-3.1
w8tywat6p85
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-5.1
nam cv91z3xzkvu
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-10.1
ji7knly2 az
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-4.1
7q83lmuf
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm